Invesaro

Stocks Health care MHUAF

OTC · Health care

Meihua International Medical Technologies Co., Ltd. (MHUAF)

Meihua International Medical Technologies Co., Ltd. reported revenue of $61.8M in fiscal 2025, down 36.2% from a year earlier. Net income was $6.8M, a net margin of 11.0%. Operating cash flow minus capital spending left $554.3K of free cash flow in fiscal 2025. At December 31, 2025 it held $15.2M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on April 29, 2026.

Watch MHUAF in 60 seconds
Price
$6.62
0.00% on the day · September 28, 2026
52-week range $2.05 to $44.50
Revenue (FY2025)
$61.8M
-36.2% year on year
Net margin
11.0%

What Meihua International Medical Technologies Co., Ltd. does

Meihua International Medical Technologies Co., Ltd. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on OTC under the ticker MHUAF.

Revenue and profit by year

Revenue
FY19: $79.6M $79.6M FY19FY21: $89.1M $89.1M FY21FY21: $104M $104M FY21FY22: $103.3M $103.3M FY22FY23: $97.1M $97.1M FY23FY24: $96.9M $96.9M FY24FY25: $61.8M $61.8M FY25
Net income
FY19: $15.4M $15.4M FY19FY21: $19M $19M FY21FY21: $20.9M $20.9M FY21FY22: $6.2M $6.2M FY22FY23: $11.6M $11.6M FY23FY24: $10.8M $10.8M FY24FY25: $6.8M $6.8M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$61.8M$8.3M$6.8M$18.04$554.3K
2024$96.9M$14.3M$10.8M$39.62$14.5M
2023$97.1M$14.7M$11.6M$48.56$1.1M
2022$103.3M$10.8M$6.2M$26.76-$11.9M
2021$104M$26.3M$20.9M$104.06-$904.9K
2021$89.1M$23.5M$19M$94.15$1.5M

Full financial statements: income, balance sheet and cash flow

Where MHUAF ranks in Health care

Revenue$61.8M
#379 of 742 in Health care · Bottom 49%
Revenue growth-36.2%
#510 of 529 in Health care · Bottom 4%
Net margin11.0%
#104 of 541 in Health care · Top 19%
Free cash flow margin0.9%
#229 of 488 in Health care · Top 47%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Meihua International Medical Technologies Co., Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. June 26, 2026
    Foreign issuer update 6-K
  2. April 29, 2026
    Annual report (foreign issuer) 20-F · period to December 31, 2025Revenue fell 36% to $61.8M versus the prior year; diluted EPS $18.04 versus $39.62.
  3. March 2, 2026
    Foreign issuer update 6-K
  4. February 24, 2026
    Form F-3 filing F-3
  5. February 2, 2026
    Foreign issuer update 6-K
  6. January 23, 2026
    Foreign issuer update 6-K
  7. January 20, 2026
    Foreign issuer update (amended) 6-K/A
  8. January 7, 2026
    Foreign issuer update 6-K
  9. December 16, 2025
    Foreign issuer update 6-K
  10. November 18, 2025
    Foreign issuer update 6-K

Recent insider filings (Forms 3, 4 and 144): 7, the latest on March 31, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about MHUAF

What does Meihua International Medical Technologies Co., Ltd. do?

Meihua International Medical Technologies Co., Ltd. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on OTC under the ticker MHUAF.

Is Meihua International Medical Technologies Co., Ltd. profitable?

Yes. In fiscal 2025 it reported net income of $6.8M on revenue of $61.8M, a net margin of 11.0%.

How much revenue does Meihua International Medical Technologies Co., Ltd. make?

In fiscal 2025 Meihua International Medical Technologies Co., Ltd. reported revenue of $61.8M. That is 36.2% less than a year earlier.

When did Meihua International Medical Technologies Co., Ltd. last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on April 29, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from June 26, 2026.

Similar companies

MDLN
Medline Inc.
SYK
Stryker Corp
MMM
3M Co
BDX
Becton Dickinson & Co
BSX
Boston Scientific Corp
BAX
Baxter International Inc

Compare MHUAF with

Compare MHUAF with any company

Follow MHUAF

Get an email when Meihua International Medical Technologies Co., Ltd. files with the SEC: results, executive changes, material agreements and annual reports.

Follow MHUAF: get an email when it files

Where the numbers come from

Financial figures are the values Meihua International Medical Technologies Co., Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.